The burgeoning popularity of tirzepatide , initially for blood sugar control , is creating significant buzz within the British Isles, prompting a notable shift in peptide trends. Access these compounds remains a complex landscape, with National Health Service provision currently limited and independent providers offering therapy at a premium . Worr